ZA974978B - Formulation and method for treating congestive heart failure - Google Patents
Formulation and method for treating congestive heart failureInfo
- Publication number
- ZA974978B ZA974978B ZA974978A ZA974978A ZA974978B ZA 974978 B ZA974978 B ZA 974978B ZA 974978 A ZA974978 A ZA 974978A ZA 974978 A ZA974978 A ZA 974978A ZA 974978 B ZA974978 B ZA 974978B
- Authority
- ZA
- South Africa
- Prior art keywords
- formulation
- heart failure
- congestive heart
- treating congestive
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65946396A | 1996-06-06 | 1996-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA974978B true ZA974978B (en) | 1998-12-07 |
Family
ID=24645503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA974978A ZA974978B (en) | 1996-06-06 | 1997-06-05 | Formulation and method for treating congestive heart failure |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0914128A1 (ko) |
JP (1) | JP2000511906A (ko) |
KR (1) | KR20000016406A (ko) |
CN (1) | CN1226166A (ko) |
AU (1) | AU3233197A (ko) |
BR (1) | BR9709546A (ko) |
CA (1) | CA2256720A1 (ko) |
CZ (1) | CZ397698A3 (ko) |
EA (1) | EA199900006A1 (ko) |
HU (1) | HUP0003885A2 (ko) |
IL (1) | IL126966A0 (ko) |
NO (1) | NO985695L (ko) |
PL (1) | PL330637A1 (ko) |
TR (1) | TR199802496T2 (ko) |
WO (1) | WO1997046241A1 (ko) |
YU (1) | YU55998A (ko) |
ZA (1) | ZA974978B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19815411A1 (de) * | 1998-04-06 | 1999-10-07 | Solvay Pharm Gmbh | Thermogenese stimulierend wirksame Arzneimittel |
AU2727400A (en) * | 1999-01-29 | 2000-08-18 | Eli Lilly And Company | Moxonidine salts |
ATE286731T1 (de) * | 1999-02-01 | 2005-01-15 | Solvay Pharm Gmbh | Verwendung von moxonidin zur behandlung nach herzinfarkt |
DE602006018139D1 (de) * | 2006-08-31 | 2010-12-23 | Chemagis Ltd | Verwendung der Monoxidinssalze zur Reinigung von Monoxidin |
KR100812287B1 (ko) * | 2007-01-03 | 2008-03-13 | 주식회사 챠콜코리아 | 내면에 반사층을 갖는 신호등 갓 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4323570A (en) * | 1978-11-15 | 1982-04-06 | Beiersdorf Aktiengesellschaft | Substituted aminopyrimidines |
DE3617158C2 (de) * | 1986-05-22 | 1994-10-06 | Lohmann Therapie Syst Lts | Transdermales Arzneimittel |
DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
DE3904795C2 (de) * | 1989-02-17 | 2000-10-12 | Lilly Pharma Produktion Gmbh & | Pharmazeutisches Präparat und dessen Verwendung |
DE4325491A1 (de) * | 1993-07-29 | 1995-02-02 | Boehringer Ingelheim Kg | Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels |
DE4423177A1 (de) * | 1994-07-01 | 1996-01-04 | Kali Chemie Pharma Gmbh | Antihyperglykämisch wirksame Arzneimittel |
CA2182851A1 (en) * | 1995-08-15 | 1997-02-16 | August Masaru Watanabe | Method for treating substance abuse withdrawal |
-
1997
- 1997-06-05 WO PCT/US1997/009914 patent/WO1997046241A1/en not_active Application Discontinuation
- 1997-06-05 CZ CZ983976A patent/CZ397698A3/cs unknown
- 1997-06-05 AU AU32331/97A patent/AU3233197A/en not_active Abandoned
- 1997-06-05 PL PL97330637A patent/PL330637A1/xx unknown
- 1997-06-05 ZA ZA974978A patent/ZA974978B/xx unknown
- 1997-06-05 KR KR1019980709980A patent/KR20000016406A/ko not_active Application Discontinuation
- 1997-06-05 CN CN97196854A patent/CN1226166A/zh active Pending
- 1997-06-05 EP EP97928011A patent/EP0914128A1/en not_active Withdrawn
- 1997-06-05 CA CA002256720A patent/CA2256720A1/en not_active Abandoned
- 1997-06-05 BR BR9709546A patent/BR9709546A/pt not_active Application Discontinuation
- 1997-06-05 IL IL12696697A patent/IL126966A0/xx unknown
- 1997-06-05 JP JP10500901A patent/JP2000511906A/ja active Pending
- 1997-06-05 HU HU0003885A patent/HUP0003885A2/hu unknown
- 1997-06-05 TR TR1998/02496T patent/TR199802496T2/xx unknown
-
1998
- 1998-12-04 YU YU55998A patent/YU55998A/sr unknown
- 1998-12-04 NO NO985695A patent/NO985695L/no not_active Application Discontinuation
-
1999
- 1999-01-06 EA EA199900006A patent/EA199900006A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EP0914128A1 (en) | 1999-05-12 |
NO985695L (no) | 1999-02-04 |
WO1997046241A1 (en) | 1997-12-11 |
TR199802496T2 (xx) | 1999-02-22 |
CN1226166A (zh) | 1999-08-18 |
NO985695D0 (no) | 1998-12-04 |
IL126966A0 (en) | 1999-09-22 |
JP2000511906A (ja) | 2000-09-12 |
PL330637A1 (en) | 1999-05-24 |
EA199900006A1 (ru) | 1999-06-24 |
CA2256720A1 (en) | 1997-12-11 |
KR20000016406A (ko) | 2000-03-25 |
AU3233197A (en) | 1998-01-05 |
YU55998A (en) | 1999-11-22 |
HUP0003885A2 (hu) | 2001-04-28 |
BR9709546A (pt) | 1999-08-10 |
CZ397698A3 (cs) | 1999-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1007152A4 (en) | METHOD AND APPARATUS FOR TREATING CARDIAC ARRHYTHMIA | |
IL128545A0 (en) | Method for treating and preventing heart failure and ventricular dilatation | |
AU2531297A (en) | Method and apparatus for rate-responsive cardiac pacing | |
IL131821A0 (en) | Defibrillator apparatus and method | |
AU2543097A (en) | Method for treating pain | |
AU2587297A (en) | Method for treating pain | |
ZA97947B (en) | Method and apparatus for applying tissue seaplant. | |
AU7568698A (en) | Method and apparatus for dermatology treatment | |
AU5242698A (en) | Method of pressure treating boards | |
IL129272A0 (en) | Method and composition for treating skin damage | |
ZA977564B (en) | Method of treatment | |
HU9900386D0 (en) | Method for treating heart failure | |
GB9511889D0 (en) | Compensation method and apparatus | |
HK1020638A1 (en) | Dc offset compensation method and apparatus | |
AU4419297A (en) | Method and apparatus for web treatment | |
GB9605828D0 (en) | Treatment method | |
AU2340897A (en) | Method for treating pain | |
PL328964A1 (en) | Acne treating method | |
ZA974978B (en) | Formulation and method for treating congestive heart failure | |
GB9618341D0 (en) | Method of treatment | |
ZA973988B (en) | Method of treatment | |
IL125762A0 (en) | Method for treating heart failure | |
AU2769497A (en) | Therapy apparatus and method | |
AU2492297A (en) | Method for treating congestive heart failure | |
HU9903735D0 (en) | Method for treating congestive heart failure |